Latest Study on “Bioimpedance Analyzers Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2027”.
The global Bioimpedance Analyzers market size is expected to be worth around US$ 773 Million by 2027, according to a new report by nova one advisor.
The global Bioimpedance Analyzers market size was valued at US$ 430 Million in 2020 and is anticipated to grow at a CAGR of 12.0% during forecast period 2021 to 2027.
Overview of Bioimpedance Analyzers Market Study
Bioimpedance Analyzers market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.
Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/5781
Growth of the market is driven mainly by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.
Global Bioimpedance Analyzers Market Dynamics
DRIVER: Increasing prevalence of lifestyle diseases
Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes.
According to the CDC, the global prevalence of obesity increased to 42.4% in 2019 from 30.5% in 2000. Obesity is now termed a worldwide epidemic; approximately 57.8% of all adults are expected to be classified as obese by 2030 (Source: WHO, 2020). In addition to developed countries, obesity is now an epidemic in low- and middle-income countries as well. As of 2019, in Africa, the prevalence of childhood obesity has increased by approximately 24% since 2000. Bioimpedance analyzers offer an accurate measurement of the amount of fat, muscle, and bone in the human body. This will fueling the growth of the bioimpedance analyzers market.
OPPORTUNITY: Emerging market across the Asia Pacific and Latin America
Emerging economies such as India, China, and Brazil are expected to witness high growth in the bioimpedance analyzers market. This can be attributed to the increasing prevalence of lifestyle diseases, growing awareness about health and obesity, and infrastructural improvements in these countries. China is a prominent market in this regard, given its recent infrastructural improvements, rapid economic growth, rising domestic demand, and public-private initiatives to support healthcare research. China’s State Council approved the 2016–2020 National Fitness Plan, which has motivated all national fitness levels and increased sports participation.
CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers
Although the technology is improving, it is difficult to obtain accurate body fat measurements from most commercially available body fat analyzers. The working of analyzers includes passing an electrical current that follows the path of least resistance through the body. As fat contains less water, the fat-free mass has less resistance to electrical current. However, a large amount of fat underneath the skin is not detected by these analyzers. In addition, body impedance varies among different ethnic groups and influences the accuracy of body composition analyzers.
The multi-frequency bioimpedance analyzers segment is expected to grow at the highest CAGR during the forecast period
Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to witness the highest growth during the forecast period. The preference for multi-frequency bioimpedance analyzers is high among end users as they can be used for both segmental and whole-body measurement, unlike single-frequency bioimpedance analyzers.
The application segment accounted for the largest share of the bioimpedance analyzers market in 2020
By application, the bioimpedance analyzers market is a segmented segmental body measurement and whole body measurement. The segmental body measurement segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the increasing prevalence of obesity and metabolic disorders.
Fitness club and wellness centers for the largest share of the bioimpedance analyzers market in 2020
Based on end-users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs and wellness centers, home users, and other end users The fitness clubs and wellness centers segment accounted for the largest share of the bioimpedance analyzers market in 2020. The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are the major driving factor for this market.
North America accounted for the largest share of the bioimpedance analyzers market in 2020
Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.
Buy Complete Assessment of Bioimpedance Analyzers market Now@ https://www.novaoneadvisor.com/report/checkout/5781
COVID-19 Impact on Bioimpedance Analyzers Sales
Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Bioimpedance Analyzers market.
Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Bioimpedance Analyzers market 2021 onwards. This trend will however continue through the course of the report’s assessment period
This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Bioimpedance Analyzers market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Some of the prominent players in the Bioimpedance Analyzers market include:
Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare, Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., Bodystat Ltd., Maltron International, Biotekna, Withings, Biodynamics Corporation, Akern, Xiaomi.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
- Multi-frequency Analyzers
- Single-frequency Analyzers
- Dual-frequency Analyzers
- Wired Bioimpedance Analyzers
- Wireless Bioimpedance Analyzers
- Whole-body Measurement
- Segmental Body Measurement
- Fitness Clubs and Wellness Centers
- Home Users
- Other End User
Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/bioimpedance-analyzers-market
Why Buy this Report?
The purpose of Nova one advisor’s Bioimpedance Analyzers market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/5781
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Call: +1 9197 992 333